(Q44288279)

1 December 2017

Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats (English)

1 reference

1 December 2017

0 references

Marín S

1

1 reference

1 December 2017

Marco E

2

1 reference

1 December 2017

Biscaia M

3

1 reference

1 December 2017

Fernández B

4

1 reference

1 December 2017

Rubio M

5

1 reference

1 December 2017

Guaza C

6

1 reference

1 December 2017

Schmidhammer H

7

1 reference

1 December 2017

Viveros MP

8

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Pharmacology, Biochemistry and Behavior

1 December 2017

1 reference

1 December 2017

74

1 reference

1 December 2017

649-656

1 reference

1 December 2017

3

1 reference

A comparative study of the effects of morphine in the dorsal periaqueductal gray and nucleus accumbens of rats submitted to the elevated plus-maze test.

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Developmental responses to opioids reveals a lack of effect on stress-induced corticosterone levels in neonatal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Behavioral effects of cannabinoid agents in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Effects of selective opioid-receptor blockade on the hypothalamo-pituitary-adrenocortical responses to surgical trauma in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Effects of opiate antagonists and putative kappa agonists on unpunished and punished operant behavior in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Effects of naltrexone on plasma corticosterone in opiate-naive rats: a central action

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Postnatal naltrindole treatments induce behavioural modifications in preweanling rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Reductions in locomotor activity following central opioid receptor subtype antagonists in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Pharmacological and biochemical interactions between opioids and cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Characterization of the acute endocrine actions of (-)-11-hydroxy-delta8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Aversive effects of the synthetic cannabinoid CP 55,940 in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Blockade of mu- and activation of kappa-opioid receptors in the dorsal periaqueductal gray matter produce defensive behavior in rats tested in the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Endocrine actions of opioids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Synergistic interactions of endogenous opioids and cannabinoid systems

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2901041-9

7 January 2021

10.1016/S0091-3057(02)01041-9

Identifiers

DOI

1 reference

1 December 2017

1 reference